Delivery Order SPE2DB22D3102-SPE2DB25FL2LQ
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of HAVRIX 1,440 unit/mL syringes, a hepatitis A vaccine product. This non-set-aside, competitively awarded contract is structured as a delivery order with firm fixed pricing and a ceiling value of $3,059.79. The contract is anticipated to reach ultimate completion on July 21, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $3,776.30 delivery order to AmerisourceBergen Drug Corp for Havrix 720 Unit/0.5 mL syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract represents a pediatric hepatitis A vaccine delivery through AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,490.36 to AmerisourceBergen Drug Corp for the supply of HAVRIX 1,440 Unit/ML vaccine syringes. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Havrix 720 Unit/0.5 ML syringes, with a ceiling value of $1,012.20 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,012.20 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine product, reflecting the ongoing federal medical procurement needs for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,136.36 for 1,440 units/mL of HAVRIX vaccine syringes on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a single transaction under the company's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a $11,463.02 delivery order to AmerisourceBergen Drug Corp for 1,440 units/mL of HAVRIX vaccine syringes on July 28, 2025, with completion targeted for July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.20 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 mL syringes on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used across military and federal healthcare systems to support troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,024.40 to AmerisourceBergen Drug Corp on January 13, 2025, for the supply of HAVRIX 720 Unit/0.5 ML syringes. This firm fixed-price, non-set-aside contract will be completed by January 14, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used in military and federal healthcare settings, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,471 to Amerisourcebergen Drug Corporation for 720 units of HAVRIX 720, a hepatitis A vaccine. The delivery order was issued under an existing prime vendor contract held by Amerisourcebergen with DLA for pharmaceutical products. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one to two days in September 2023. No subcontractors or set aside...